✦ LIBER ✦

Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer

✍ Scribed by Erselcan, T; Kairemo, K J A; Wiklund, T A; Hernberg, M; Blomqvist, C P; Tenhunen, M; Bergh, J; Joensuu, H

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Scandinavian Breast Group Study SBG-

✍ Bergh, J. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 162 KB

High dose chemotherapy as adjuvant treat

✍ Eiichi Shiba; Kenji Akazawa; Seung Jin Kim; Tetsuya Taguchi; Fumine Tsukamoto; H 📂 Article 📅 2000 🏛 Springer Japan 🌐 English ⚖ 419 KB

Quality of life in women with breast can

✍ Brandberg, Y.; Michelson, H.; Bergh, J. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 187 KB

P84 High dose epirubicin and cyclophosph

✍ E. Galligioni; G. Cetto; O. Nascimben; A. Buonadonna; D. Crivellari; A. Molino; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Risk factors for early recurrences after

✍ I.F Faneyte; J.L Peterse; H Van Tinteren; C Pronk; E.G.E De Vries; S Rodenhuis; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Dose-intensified epirubicin versus stand

✍ Wolfgang Eiermann; Erika Graf; Beyhan Ataseven; Bettina Conrad; Jörn Hilfrich; H 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 665 KB